July 16, 2026 05:34 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Why introduce a new language in Class 9?' Supreme Court questions Centre's policy | 'Save Sonam Wangchuk's life': Delhi High Court to Centre as hunger strike enters Day 19 | Atul Kulkarni observes one-day fast in support of Sonam Wangchuk, urges Centre to initiate dialogue | Argentina stun England with late rally to storm into FIFA World Cup 2026 final | 'He could die in two days': Delhi HC plea seeks force-feeding of Sonam Wangchuk as fast enters Day 18 | 'Tonight's defeat is hard to take': Emmanuel Macron reacts after France crash out of World Cup, congratulates Spain | Spain cruise past France to storm into FIFA World Cup 2026 final with clinical 2-0 victory | Taslima Nasrin announces Kolkata return after 20 years to attend literary event at Rabindra Sadan | 'We must not watch one of our greatest minds be sacrificed': Zeenat Aman backs Sonam Wangchuk, urges govt to open dialogue | 'I don't want Phunsukh Wangdu to die': '3 Idiots' star Omi Vaidya's emotional appeal for Sonam Wangchuk
Johnson Baby Powder
Image Credit: wikipedia.org

Maharashtra FDA cancels Johnson & Johnson baby powder licence

| @indiablooms | Sep 18, 2022, at 05:06 am

Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, Mulund, after the department found it "Not Of Standard Quality".

The FDA said that the licence was cancelled after samples of the Johnson’s Baby Powder collected from Nashik and Pune failed quality checks and ordered the company to recall all its stocks from the markets.

These samples were declared by the FDA as ‘Not Of Standard Quality’ after they failed to comply with IS5339:2009 (Second Revision Amendment No. 3) Specification for Skin Powder for infants in the test pH.

In a statement, the FDA said: “The product Johnsons Baby Powder is popularly used in newborn babies. The sample declared 'Not of Standard' in pH and the use of the product may affect the health of the skin of the newborn babies.”

The firm "didn't accept the report" and challenged it in court for sending it to the Central Drugs Laboratory, the FDA said, according to media reports.

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.